Wiley Blackwell

SHERPA: Unknown

People

  1. Gonen
    Gonen
  2. Panageas
    Panageas
  3. Seshan
    Seshan
  4. Begg
    Begg
  5. Chou
    Chou
  6. Zhang
    Zhang
  7. Capanu
    Capanu
  8. Hudis
    Hudis
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Biostatistics Service (310)
  2. Epidemiology and Biostatistics (310)
  3. Department of Medicine (179)
  4. Solid Tumor Oncology Division (146)
  5. Population Sciences Research Program (135)
  6. Survivorship Research (135)
  7. Surgery (116)
  8. Center for Pancreatic Cancer Research (113)
  9. Department of Pathology and Laboratory Medicine (70)
  10. GSK Faculty (64)
Search Within
  1. "Biostatistics Service"
Formats
  1. Journal Article (278)
  2. Meeting Abstract (30)
  3. Book Section (1)
  4. Research Letter (1)
Groups
  1. Biostatistics Service (310)
  2. Epidemiology and Biostatistics (310)
  3. Department of Medicine (179)
  4. Solid Tumor Oncology Division (146)
  5. Population Sciences Research Program (135)
  6. Survivorship Research (135)

More Groups

People
  1. Mithat Gonen (41)
  2. Katherine Panageas (38)
  3. Sujata Patil (33)
  4. Marinela Capanu (31)
  5. Venkatraman Seshan (28)
  6. Colin Begg (27)

More People

Years
  1. 2025 (5)
  2. 2024 (5)
  3. 2023 (16)
  4. 2022 (9)
  5. 2021 (13)
  6. 2020 (21)

More Years

Publications
  1. Cancer (153)
  2. Biometrics (27)
  3. Journal of Surgical Oncology (25)
  4. Hematological Oncology (21)
  5. Cancer Medicine (16)
  6. BJU International (7)

More Publications

Results (310)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor–mutant lung cancers and brain metastases
    Journal Article

    Arbour, K. C.; Kris, M. G.; Riely, G. J.; Ni, A.; Beal, K.; Daras, M.; Hayes, S. A.; Young, R. J.; Rodriguez, C. R.; Ahn, L.; more...
    Cancer (2018)

    Fulltext@MSK | Save
  • A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma
    Journal Article

    Lowery, M. A.; Yu, K. H.; Kelsen, D. P.; Harding, J. J.; Bomalaski, J. S.; Glassman, D. C.; Covington, C. M.; Brenner, R.; Hollywood, E.; Barba, A.; more...
    Cancer (2017)

    Fulltext@MSK | Save
  • Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancer
    Journal Article

    Zumsteg, Z. S.; Zelefsky, M. J.; Woo, K. M.; Spratt, D. E.; Kollmeier, M. A.; McBride, S.; Pei, X.; Sandler, H. M.; Zhang, Z.
    BJU International (2017)

    Fulltext@MSK | Save
  • Phase I designs that allow for uncertainty in the attribution of adverse events
    Journal Article

    Iasonos, A.; O'Quigley, J.
    Journal of the Royal Statistical Society Series C - Applied Statistics (2017)

    Fulltext@MSK | Save
  • No association between prediagnosis exercise and survival in patients with high-risk primary melanoma: A population-based study
    Journal Article

    Schwitzer, E.; Orlow, I.; Zabor, E. C.; Begg, C. B.; Berwick, M.; Thomas, N. E.; Kanetsky, P. A.; Jones, L. W.; for the GEM Study Group
    Pigment Cell & Melanoma Research (2017)

    Fulltext@MSK | Save
  • Are there patients with T1 to T2, lymph node-negative breast cancer who are “high-risk” for locoregional disease recurrence?
    Journal Article

    Mamtani, A.; Patil, S.; Stempel, M. M.; Morrow, M.
    Cancer (2017)

    Fulltext@MSK | Save
  • Langerhans cell histiocytosis in adults is associated with increased hematologic and solid malignancies
    Meeting Abstract

    Ma, J.; Laird, J.; Chau, K.; Chelius, M.; Bell, A. C.; Zhang, Z.; Lok, B. H.; Yahalom, J.
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • ME-401, a novel, oral, potent and selective inhibitor of phosphatidylinositol 3-kinase P110δ (PI3Kδ) in early clinical development for B-cell lymphoid malignancies
    Meeting Abstract

    Ghalie, R. G.; Pagel, J. M.; Soumerai, J.; Iasonos, A.; Patel, K.; Moreno, O.; Butler, T.; Zelenetz, A. D.
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Defining progression free survival after multiple lines of therapy and impact of dynamic changes in FLIPI for multiply relapsed follicular lymphoma in the rituximab era
    Meeting Abstract

    Batlevi, C.; Alperovich, A.; Ni, A.; Soumerai, J.; Smith, K.; Ying, Z.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Time from prognosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma
    Meeting Abstract

    Soumerai, J. D.; Ni, A.; Batlevi, C.; Alperovich, A.; Bantilan, K. S.; Palomba, M.; Gerecitano, J. F.; Noy, A.; Hamlin, P.; Moskowitz, C. H.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save